PMA Parallels
This article was originally published in The Gray Sheet
Executive Summary
Harvard cardiologist and device safety expert William Maisel sees a parallel "loophole" in FDA's model for assessing modifications to existing PMA products, which he says allows too many products on the market by means of a PMA supplement, which is less rigorous than a full PMA application.